Matthew D. Hellmann
Matthew Hellmann is a medical oncologist who specializes in the care of patients with lung cancers, particularly non small-cell lung cancers. He is dedicated to identifying better treatments for people with all stages of disease and to providing compassionate care for patients and their families. His research focuses on developing innovative and effective ways to harness the body’s immune system to fight cancer. He is a member of the MSK’s Immunotherapeutics Group, where they design and lead early-phase clinical trials of immunotherapies for patients with a variety of different cancers.
Abstracts this author is presenting:
